CDKN2A突变:患者和医生的经验
Yaelle Shaked1,2, Alyssa Swearingen1,3, Tracey N Liebman4
1Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York University Grossman School of Medicine, 240 E 38th St, 11th Floor, New York, NY, 10016, USA.
Dermatology and therapy
|February 8, 2025
概括
CDKN2A突变带来重大风险,特别是在家族性黑色素瘤患者身上. 通过基因检测和定期皮肤监测进行早期检测对于管理这种遗传性癌症风险至关重要.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
背景情况:
- 这篇文章探讨了患者和医生对CDKN2A突变的看法.
- 它详细介绍了患者的个人旅程,包括基因测试的原因以及诊断对他的家人的影响.
更多相关视频
11:15Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
24.3K
06:59Using Next Generation Sequencing to Identify Mutations Associated with Repair of a CAS9-induced Double Strand Break Near the CD4 Promoter
Published on: March 31, 2022
2.4K
